ADMA Biologics Inc Common Stock is a biopharmaceutical company that develops, manufactures, and commercializes plasma-based biologics for the treatment of immune deficiencies and infectious diseases. They aim to provide patients with safe and effective therapies while also optimizing the supply chain to ensure access to these life-saving treatments.
